An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

NCT05559606 · clinicaltrials.gov ↗
COMPLETED
Status
1839
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boryung Pharmaceutical Co., Ltd